Filing Flows › Utah Medical Products (UTMD) › Q2 2025
Utah Medical Products (UTMD) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
Utah Medical Products (UTMD) reported revenue of $10.0M for the second quarter 2025 (Q2 2025), -4% from a year earlier and +3% from the quarter before. Operating margin was 32.1%, net earnings $3.0M (30.6% of revenue).
Utah Medical Products, Q2 2025: revenue $10.0M (-4% year over year), operating margin 32.1%, net earnings $3.0M, operating cash flow $2.9M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.0M | +3% | -4% |
| Gross profit | $5.6M | +1% | -11% |
| Operating profit | $3.2M | +1% | -7% |
| Net earnings | $3.0M | +0.2% | -12% |
| Operating cash flow | $2.9M | -36% | +4% |
| Free cash flow | $2.8M | -34% | +6% |
What changed
Revenue was $10.0M in Q2 2025, down 4% year over year and up 3% from the previous quarter. Gynecology/Electrosurgery/Urology was the largest line at 48% of revenue.
Gross margin was 56.2%, down 3.9 points from a year earlier. Operating profit was $3.2M, a 32.1% margin (down 0.9 points year over year). Operating expenses fell 15% while revenue fell 4%. Net earnings were $3.0M, down 12% year over year. The effective tax rate was 20.5%.
Operating cash flow was $2.9M (up 4% year over year), 94% of net earnings. Non-cash charges added back $744K of depreciation and amortization and $86K of share-based compensation. Working capital and other items used $1.0M. Capital expenditures of $51K left free cash flow of $2.8M.
Questions
What was Utah Medical Products' revenue in the second quarter 2025?
Utah Medical Products (UTMD) reported revenue of $10.0M for the second quarter 2025 (Q2 2025), -4% from a year earlier and +3% from the quarter before.
Was Utah Medical Products profitable in the second quarter 2025?
Operating profit was $3.2M (32.1% of revenue) and net earnings $3.0M.